Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session

Monday
May 09
14:15 - 15:30
Room D4
This house believes that an intensive follow up for high-risk breast cancer patients should be considered
Icro Meattini, Italy;
Philip Poortmans, Belgium
This mind-challenging debate focuses on whether treating physicians or patients themselves should be in charge for follow-up after breast cancer treatment. By discussing the possible value of early detection of recurrences, the definition of high-risk patients, tools to detect recurrences, needs for evaluation of side effects, optimisation of physical and psychological well-being, and physical as well as emotional costs of follow-up examinations and visits, the debaters will try to convince us of their viewpoints. They will focus on patients’ and clinicians’ perspectives, patients’ empowerment, and not avoid a black & white position. A not to be missed debate!
Debate
Clinical
14:15 - 14:17
Introduction
SP-0848
14:17 - 14:32
Desiree van den Bongard, The Netherlands
SP-0849
14:32 - 14:47
Indrani Bhattacharya , United Kingdom
SP-0850
14:47 - 15:02
Pierfrancesco Franco, Italy
SP-0851
15:02 - 15:17
Orit Kaidar-Person, Israel
SP-0852
15:17 - 15:30
Discussion
SP-0853